That's exactly right SSV.
Your so-called assumptions are entirely consistent with my reaesrch.
Demand trends showed up in the last quarterly - and will be even more evident in the current quarter (as will be confirmed late Jan). Also apparent very large backlog in supply to distributors.
And the main thing - all this while one of the key products (oraline) is essentially off the market (until FDA clearance)
- Forums
- ASX - By Stock
- SBN
- placement
placement, page-23
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SBN (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online